search
Back to results

Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV

Primary Purpose

Benign Paroxysmal Positional Vertigo

Status
Not yet recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Group A
Group B
Sponsored by
Xi'an No.3 Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Benign Paroxysmal Positional Vertigo

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: According to the diagnostic criteria and therapeutic efficacy evaluation for benign paroxysmal positional vertigo (BPPV) formulated by the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association, the patient was confirmed as having BPPV and the repositioning maneuver was successful. After the maneuver, the patient's clinical symptoms were relieved, with no sense of rotation or dizziness, but residual symptoms such as discomfort and unsteady gait persisted. There were no obvious communication barriers or visual impairments. The patient and their family members agreed to the treatment plan. Exclusion Criteria: Patients with other ear diseases, history of head trauma or surgery; Patients who are weak and unable to tolerate, pregnant women; Patients who have undergone vestibular rehabilitation training before this treatment; ④ Patients with joint diseases that affect balance and walking; ⑤ Patients with a history of brain organic diseases (such as tumors, stroke, cerebral hemorrhage) or severe neurological diseases; ⑥ Patients with incomplete data or who withdraw from treatment midway.

Sites / Locations

  • Xi'an No3 Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Group A (acupuncture group)

Group B (betahistine group)

Arm Description

Treatment patients with residual symptoms after successful manual repositioning by electroacupuncture

Treatment patients with residual symptoms after successful manual repositioning by oral betahistine

Outcomes

Primary Outcome Measures

Visual Analog Scale (VAS) score
A scale used to evaluate the degree of dizziness in patients, scores range from 0 to 10, with higher scores indicating more severe degree of dizziness they feel.
Dizziness Handicap Inventory
Self-perceived handicapping effects imposed by dizziness. Internal consistency (Cronbach's alpha: 0.92), Test-retest reliability r = 0.95

Secondary Outcome Measures

Foam posturography
The sponge-cushion posturing is a quantitative method for measuring postural stability. The test-retest reliability of sponge-cushion posturing is good (ICC = 0.887-0.973)

Full Information

First Posted
May 11, 2023
Last Updated
August 13, 2023
Sponsor
Xi'an No.3 Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT06001047
Brief Title
Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV
Official Title
Effect of Head Acupuncture on Residual Symptoms After Canalith Repositioning Procedure for Benign Paroxysmal Positional Vertigo: a Single-center Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 1, 2023 (Anticipated)
Primary Completion Date
July 1, 2026 (Anticipated)
Study Completion Date
November 1, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Xi'an No.3 Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, and currently, manual repositioning techniques are often used for treatment. However, up to 30%-50% of patients may experience residual symptoms such as non-rotational dizziness, heaviness, instability, and emotional disturbances even after successful repositioning, which significantly impacts their daily functioning and quality of life. Electroacupuncture therapy has been proven to be an effective treatment for dizziness and has been applied to various vestibular disorder patients. However, the efficacy of electroacupuncture on the residual effects of successfully repositioned BPPV patients remains unclear. This study aims to explore the effectiveness of three regimens: electroacupuncture, betahistine in patients with residual symptoms after successful manual repositioning.
Detailed Description
Research objectives: Explore the risk factors that influence residual effects after BPPV and develop a predictive score chart. Determine the gait characteristics of patients with residual effects after successful repositioning of BPPV. Compare the clinical efficacy of different intervention strategies for the treatment of residual symptoms after successful repositioning of BPPV. Research subjects: From June 2023 to June 2024, patients aged between 18-65 who are first diagnosed with BPPV will be recruited from the outpatient and inpatient departments of the Third Hospital of Xi'an City, affiliated to Northwest University. For posterior canal BPPV, Epley or Semont maneuver will be performed; for horizontal canal BPPV, Gufoni maneuver will be performed; for anterior canal BPPV, Yacovino maneuver will be performed. The patients will be observed for 30 minutes after the positioning maneuver to confirm the successful repositioning. On the second day after the maneuver, the follow-up personnel of the research team will contact the patient by phone or online to determine whether they have residual dizziness symptoms and whether they are willing to participate in the study. Those who agree can come to the hospital for reassessment to confirm the successful repositioning. Residual symptom evaluation criteria: On the 2nd day after successful repositioning, ask the patient if they have persistent nonspecific symptoms such as dizziness, feeling of heaviness in the head, unsteadiness, or floating sensation, without positional vertigo. Sample size estimation: According to the sample size design plan of randomized controlled studies, with a Type I error of α=0.05, a Type II error of 1-β=0.8, an incidence rate of P1=0.6 in the intervention group, an incidence rate of P2=0.45 in the control group, and a 1:1 ratio, 50 participants are allocated to each group with a total of 150 participants. Assuming a certain proportion of dropouts in each group, the sample size of each group required for enrollment is 60 participants. Randomization and blinding: The postoperative patients were randomly divided into two groups: Group A (acupuncture group) and Group B (betahistine group) using SPSS 20.0 software. This study did not apply blinding to the operators or patients, while the outcome assessors and data analysts were blinded. Data collection: Baseline data including demographic information, medical history, physical examination, laboratory tests, and vestibular function tests were collected at enrollment. Dizziness Handicap Inventory (DHI) and Visual Analog Scale (VAS) scores were collected at baseline, 3 days after treatment, 1 week after treatment, 2 weeks after treatment, and 4 weeks after treatment. In addition, balance function and gait tests were performed at each time point.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Benign Paroxysmal Positional Vertigo

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group A (acupuncture group)
Arm Type
Experimental
Arm Description
Treatment patients with residual symptoms after successful manual repositioning by electroacupuncture
Arm Title
Group B (betahistine group)
Arm Type
Active Comparator
Arm Description
Treatment patients with residual symptoms after successful manual repositioning by oral betahistine
Intervention Type
Procedure
Intervention Name(s)
Group A
Other Intervention Name(s)
Scalp acupuncture
Intervention Description
Acupoint selection: The location of the vertigo-auditory area follows the positioning standard of Jiao Shunfa's Head Acupuncture. Operation: Electroacupuncture stimulation in the vertigo-auditory area of affected side. Pulse electrotherapy produced by Wujin Changcheng Medical Instrument. Sparse-dense waveforms are selected, with a voltage of 2-4V, a frequency of 60-80 times/min, and the intensity is determined by the patient's tolerance. The needle is in affected side for 30 minutes, and treatment is given once daily for a total of 5 days.
Intervention Type
Drug
Intervention Name(s)
Group B
Other Intervention Name(s)
betahistine group
Intervention Description
The original text is related to a medication called Pitavastatin Calcium Tablets, commonly known as "Minshilang" in Chinese, produced by Weicai (China) Pharmaceutical Co., Ltd. The dosage is 12mg, three times a day (Tid) for four consecutive weeks. Compliance monitoring is conducted by counting the remaining tablets in the medication packaging box brought by patients during the 4-week follow-up period. Concurrent use of other medications that may affect the observation results, such as anti-anxiety drugs, vestibular suppressants, and anti-dizziness Chinese patent medicines, is considered a violation of the protocol.
Primary Outcome Measure Information:
Title
Visual Analog Scale (VAS) score
Description
A scale used to evaluate the degree of dizziness in patients, scores range from 0 to 10, with higher scores indicating more severe degree of dizziness they feel.
Time Frame
1weeks after treatment
Title
Dizziness Handicap Inventory
Description
Self-perceived handicapping effects imposed by dizziness. Internal consistency (Cronbach's alpha: 0.92), Test-retest reliability r = 0.95
Time Frame
1weeks after treatment
Secondary Outcome Measure Information:
Title
Foam posturography
Description
The sponge-cushion posturing is a quantitative method for measuring postural stability. The test-retest reliability of sponge-cushion posturing is good (ICC = 0.887-0.973)
Time Frame
1weeks after treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: According to the diagnostic criteria and therapeutic efficacy evaluation for benign paroxysmal positional vertigo (BPPV) formulated by the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association, the patient was confirmed as having BPPV and the repositioning maneuver was successful. After the maneuver, the patient's clinical symptoms were relieved, with no sense of rotation or dizziness, but residual symptoms such as discomfort and unsteady gait persisted. There were no obvious communication barriers or visual impairments. The patient and their family members agreed to the treatment plan. Exclusion Criteria: Patients with other ear diseases, history of head trauma or surgery; Patients who are weak and unable to tolerate, pregnant women; Patients who have undergone vestibular rehabilitation training before this treatment; ④ Patients with joint diseases that affect balance and walking; ⑤ Patients with a history of brain organic diseases (such as tumors, stroke, cerebral hemorrhage) or severe neurological diseases; ⑥ Patients with incomplete data or who withdraw from treatment midway.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mingze Chang, PhD
Phone
029+8661816100
Email
changmingze191@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mingze Zhao, PhD
Organizational Affiliation
Xi'an No.3 Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Xi'an No3 Hospital
City
Xi'an
Country
China
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mingze Chang
Phone
changmingze191@163.com
Email
changmingze191@163.com
First Name & Middle Initial & Last Name & Degree
Yong Zhao
Phone
13289867381@163.com
Email
13289867381@163.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV

We'll reach out to this number within 24 hrs